Corporations Honored for Support of Clinical Research Education
Eli Lilly & Co., a leading developer of pharmaceutical products that help people live longer, healthier and more active lives, took top honors for its support of clinical research education at the 2008 Annual Meeting of the Center for Information and Study on Clinical Research Participation (CISCRP) in June.
NEWS RELEASE
HOLD FOR RELEASE UNTIL JUNE 23, 2008, PLEASE
CORPORATIONS HONORED FOR SUPPORT OF CLINICAL RESEARCH EDUCATION
(DEDHAM, MA)- Eli Lilly & Co., a leading developer of pharmaceutical products that help people live longer, healthier and more active lives, took top honors for its support of clinical research education at the 2008 Annual Meeting of the Center for Information and Study on Clinical Research Participation (CISCRP) in June.
Lilly was awarded CISCRP’s Medical Heroes Awardfor its investment of people and funding in a wide span of critical initiatives including the AWARE for All Clinical Research Education program; new educational materials; and the development and testing of CISCRP’s new Medical Heroes public service campaign. The aptly named Medical Heroes Award links Lilly’s support with CISCRP’s groundbreaking efforts to transform the image of the clinical research volunteer from “guinea pig” to “medical hero.” In addition, Lilly has aided the development of CISCRP’s disease-specific DVD’s for African American and Hispanic audiences about the role of clinical research participation in improving minority health.
AstraZeneca, the Lupus Foundation, Ogilvy HealthWorld, and PharmaNet also were honored for their contributions to the development of new CISCRP Educational Materials, including: two specialized brochures for African-American and Hispanic audiences; 10 foreign language brochures for people in 12 different countries; and the creation of disease-specific DVDs about the risks and benefits of volunteering for clinical research studies.
Six Philadelphia academic medical centers and hospitals received CISCRP’s award for Outstanding Support of Public Outreach and Community Building for their work on behalf of the organization’s mission of educating and empowering people to make informed decisions about clinical research participation.
Children’s Hospital of Philadelphia, Drexel University School of Medicine, Fox Chase Cancer Center, Temple University, Thomas Jefferson University, and the University of Pennsylvania School of Medicine were recognized for their collaborative support and co-sponsorship of the highly successful AWARE for All-Philadelphia Clinical Research Education Day in April.
The highly successful program was attended by some 400 guests and provided free public workshops about health and the role of the clinical research volunteer. Many of the speakers and presenters were researchers and healthcare professionals from the co-sponsoring organizations.
The independent, non-profit organization, CISCRP, is a national leader in promoting public trust of the clinical research enterprise and raising public awareness of clinical research’s role in improving public health. To find out more, please visit www.CISCRP.org, email info@ciscrp.org, or phone 1-781-326-3400 or Toll Free: 1-888-CISCRP3 (247-2773).
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
